You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 16, 2025

Drug Price Trends for BACITRACIN


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for BACITRACIN

Average Pharmacy Cost for BACITRACIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
BACITRACIN 500 UNIT/GM OINTMNT 45802-0060-03 0.07980 GM 2025-05-21
BACITRACIN 500 UNIT/GM OINTMNT 45861-0073-03 0.06307 GM 2025-05-21
BACITRACIN 500 UNIT/GM OINTMNT 68001-0477-46 0.09369 GM 2025-05-21
BACITRACIN 500 UNIT/GM OINTMNT 00536-1256-28 0.06307 GM 2025-05-21
BACITRACIN 500 UNIT/GM OINTMNT 45802-0060-01 0.11661 GM 2025-05-21
BACITRACIN 500 UNIT/GM OINTMNT 00713-0280-31 0.07401 GM 2025-05-21
BACITRACIN 500 UNIT/GM OINTMNT 68001-0477-47 0.07401 GM 2025-05-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for BACITRACIN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
BACITRACIN/NEOMYCIN/POLYMYXIN B SO4 OINT,TOP United Drug Supply, Inc. 67777-0217-07 144x0.9GM 21.60 2023-12-01 - 2028-11-30 FSS
GOODSENSE FIRST AID ANTIBIOTIC OINT United Drug Supply, Inc. 00113-0084-64 28GM 4.77 0.17036 GM 2023-12-01 - 2028-11-30 FSS
BACITRACIN ZINC 500UNT/GM OINT,TOP,PKG,0.9GM United Drug Supply, Inc. 67777-0008-10 144X0.9GM 16.20 2023-12-01 - 2028-11-30 FSS
BACITRACIN 500UNT/GM OINT,TOP,PKG,0.9GM United Drug Supply, Inc. 67777-0116-10 144X0.9GM 15.30 2023-12-01 - 2028-11-30 FSS
BACITRACIN/NEOMYCIN/POLYMYXIN B SO4 OINT,TOP United Drug Supply, Inc. 67777-0217-05 144x0.5GM 18.40 2023-12-01 - 2028-11-30 FSS
BACITRACIN 500UNT/GM OINT,TOP Stratus Pharmaceuticals, Inc. 58980-0011-10 28.35GM 2.70 0.09524 GM 2023-10-01 - 2028-09-30 FSS
DOUBLE ANTIBIOTIC (B.TRACN ZN) Stratus Pharmaceuticals, Inc. 58980-0012-05 14.2GM 2.75 0.19366 GM 2023-10-01 - 2028-09-30 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Bacitracin Zinc Premix Market Analysis and Price Projections

Introduction to Bacitracin Zinc Premix

Bacitracin Zinc Premix is a formulation that combines the antibiotic Bacitracin with zinc, commonly used in veterinary care and animal nutrition. This premix is integral in promoting growth and managing bacterial infections, particularly in pigs and poultry.

Market Size and Growth Projections

The Bacitracin Zinc Premix Market has been experiencing significant growth and is projected to continue this trend. As of 2023, the market size was valued at USD 168.11 billion and is expected to reach USD 345.9 billion by the end of 2030, with a Compound Annual Growth Rate (CAGR) of 10.2% during the forecast period of 2024-2030[1][5].

Key Drivers of Market Growth

Evolving Consumer Preferences

There is a growing emphasis on sustainable and natural alternatives in animal feed, driving manufacturers to explore innovative formulations that enhance the efficacy of Bacitracin Zinc. This shift towards more sustainable practices is a significant driver of market growth[1].

Regulatory Environment

Stringent regulations regarding antibiotic use in livestock are shaping the market landscape. Regions with stricter antibiotic regulations are seeing a surge in demand for Bacitracin Zinc premixes that align with emerging industry standards. This regulatory environment is pushing the market towards more compliant and sustainable products[1].

Antibiotic Resistance Concerns

Concerns over antibiotic resistance are driving a shift towards antibiotic alternatives in animal feed. Bacitracin zinc premix, with its narrow-spectrum activity against Gram-positive bacteria, is seen as a viable option, fueling market growth[1].

Feed Efficiency and Animal Health

Rising feed costs and consumer demand for ethically sourced meat are pushing the animal feed industry towards improved feed efficiency and animal health. Bacitracin zinc premix, known for its growth-promoting and disease-preventive properties, aligns with this trend, potentially boosting market demand[1].

Market Challenges

Antibiotic Residues and Consumer Preferences

Growing awareness about antibiotic residues in animal products and consumer preferences for antibiotic-free meat products may put pressure on the market in the long term. Manufacturers are responding by developing new premix formulations with lower antibiotic content and exploring alternative feed additives[1].

Market Segmentation

The Bacitracin Zinc Premix Market is segmented based on type and application. The types include different content percentages (e.g., 10%, 15%), and the applications include various animal categories such as sheep, cows, pigs, and poultry. Geographical segmentation includes regions like North America, Europe, Asia-Pacific, South America, and the Middle East and Africa[5].

Key Players

Several key companies are prominent in the Bacitracin Zinc Premix Market, including:

  • Zoetis
  • Lifecome Biochemistry
  • Tianjin Xinxing
  • Hero Pharmaceutical
  • Fengchen
  • Huvepharma[1][3].

These companies are focusing on strategy building and expanding their product portfolios to strengthen their market presence.

Price Projections and Trends

Current Market Prices

The cost of Bacitracin Zinc Premix can vary based on the formulation and the region. However, the overall market trend indicates a rise in prices due to increasing demand and the need for more sophisticated formulations that comply with regulatory standards[1].

Future Price Trends

Given the projected growth rate of 10.2% CAGR, it is expected that the prices of Bacitracin Zinc Premix will continue to rise. This increase will be driven by the demand for high-quality, compliant products and the ongoing research and development in the field of animal nutrition[1].

Regional Analysis

The market is segmented into major regions including North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Each region has its own set of trends and growth rates, with Asia-Pacific expected to be a significant contributor to the market growth due to its large animal feed industry[3][5].

Technological and Regulatory Trends

Technological Advancements

Technological advancements in manufacturing methods and the development of new premix formulations are crucial for the market. These advancements help in improving the efficacy of Bacitracin Zinc and aligning with the evolving regulatory landscape[4].

Regulatory Compliance

Regulatory trends, including stricter regulations on antibiotic use in livestock, are shaping the market. Manufacturers must comply with these regulations, which often involves developing new products with lower antibiotic content or alternative feed additives[1].

Consumer Behavior and Economic Factors

Consumer Demand

Consumer demand for ethically sourced and sustainably produced meat products is a significant factor influencing the market. This demand drives the need for more efficient and healthy animal feed, which in turn boosts the demand for Bacitracin Zinc Premix[1].

Economic Factors

Economic factors such as rising feed costs and government spending on agricultural research and development also play a crucial role in shaping the market. These factors can influence the production costs and the overall market size[1][3].

Key Takeaways

  • The Bacitracin Zinc Premix Market is expected to grow significantly, reaching USD 345.9 billion by 2030.
  • Key drivers include evolving consumer preferences, regulatory environment, and concerns over antibiotic resistance.
  • The market faces challenges such as growing awareness about antibiotic residues and consumer preferences for antibiotic-free products.
  • Major players are focusing on strategy building and product portfolio expansion.
  • Technological advancements and regulatory compliance are crucial for market growth.

FAQs

What is the projected market size of the Bacitracin Zinc Premix Market by 2030?

The Bacitracin Zinc Premix Market is expected to reach USD 345.9 billion by the end of 2030[1].

What are the key drivers of the Bacitracin Zinc Premix Market?

Key drivers include evolving consumer preferences, stringent regulations on antibiotic use, and concerns over antibiotic resistance[1].

Which regions are expected to contribute significantly to the market growth?

Asia-Pacific is expected to be a significant contributor to the market growth due to its large animal feed industry[3][5].

How are consumer preferences impacting the Bacitracin Zinc Premix Market?

Consumer demand for ethically sourced and sustainably produced meat products is driving the need for more efficient and healthy animal feed, boosting the demand for Bacitracin Zinc Premix[1].

What are the challenges faced by the Bacitracin Zinc Premix Market?

Challenges include growing awareness about antibiotic residues in animal products and consumer preferences for antibiotic-free meat products[1].

Sources

  1. Verified Market Reports: Bacitracin Zinc Premix Market Size, Share & Growth 2031.
  2. Drugs.com: Bacitracin ophthalmic Prices, Coupons, Copay Cards & Patient Assistance.
  3. Cognitive Market Research: Veterinary Zinc Bacitracin Market Report 2024 (Global Edition).
  4. Research and Markets: Zinc bacitracin (CAS 1405-89-6) Global Market Research Report 2024.
  5. Market Research Intellect: Global Bacitracin Zinc Premix Market Size, Scope And Forecast Report.
Last updated: 2025-01-01

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.